Ligase IV syndrome can present with microcephaly and radial ray anomalies similar to Fanconi anaemia plus fatal kidney malformations.


Journal

European journal of medical genetics
ISSN: 1878-0849
Titre abrégé: Eur J Med Genet
Pays: Netherlands
ID NLM: 101247089

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 22 04 2020
accepted: 01 06 2020
pubmed: 15 6 2020
medline: 30 3 2021
entrez: 15 6 2020
Statut: ppublish

Résumé

Ligase IV (LIG4) syndrome is a rare disorder of DNA damage repair caused by biallelic, pathogenic variants in LIG4. This is a phenotypically heterogeneous condition with clinical presentation varying from lymphoreticular malignancies in developmentally normal individuals to significant microcephaly, primordial dwarfism, radiation hypersensitivity, severe combined immunodeficiency and early mortality. Renal defects have only rarely been described as part of the ligase IV disease spectrum. We identified a consanguineous family where three siblings presenting with antenatal growth retardation, microcephaly, severe renal anomalies and skeletal abnormalities, including radial ray defects. Autozygosity mapping and exome sequencing identified a novel homozygous frameshift variant in LIG4, c.597_600delTCAG, p.(Gln200LysfsTer33), which segregated in the family. LIG4 is encoded by a single exon and so this frameshift variant is predicted to result in a protein truncated by 678 amino acids. This is the shortest predicted LIG4 protein product reported and correlates with the most severe clinical phenotype described to date. We note the clinical overlap with Fanconi anemia and suggest that LIG4 syndrome is considered in the differential diagnosis of this severe developmental disorder.

Identifiants

pubmed: 32534991
pii: S1769-7212(20)30359-1
doi: 10.1016/j.ejmg.2020.103974
pmc: PMC7445424
pii:
doi:

Substances chimiques

LIG4 protein, human 0
DNA Ligase ATP EC 6.5.1.1

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103974

Subventions

Organisme : Medical Research Council
ID : MR/L002744/1
Pays : United Kingdom

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Références

Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3024-9
pubmed: 20133615
Nat Genet. 2005 May;37(5):520-5
pubmed: 15838507
Pediatr Nephrol. 2018 Sep;33(9):1547-1551
pubmed: 29651604
Nature. 1998 Nov 12;396(6707):173-7
pubmed: 9823897
Curr Biol. 1998 Dec 17-31;8(25):1395-8
pubmed: 9889105
J Immunol. 2006 Apr 15;176(8):5060-8
pubmed: 16585603
Baillieres Best Pract Res Clin Haematol. 2000 Sep;13(3):407-25
pubmed: 11030042
Mol Cell. 2001 Dec;8(6):1175-85
pubmed: 11779494
Am J Clin Pathol. 2006 Aug;126(2):256-65
pubmed: 16891202
Hum Mutat. 2006 Oct;27(10):1041-6
pubmed: 16941472
Nephrol Dial Transplant. 2001 Jun;16(6):1170-5
pubmed: 11390716
Eur J Immunol. 2006 Jan;36(1):224-35
pubmed: 16358361
Pediatr Blood Cancer. 2009 Sep;53(3):482-4
pubmed: 19418549
Nat Rev Nephrol. 2015 Feb;11(2):102-12
pubmed: 25536396
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Hum Mutat. 2014 Jan;35(1):76-85
pubmed: 24123394
J Med Genet. 2003 Jan;40(1):1-10
pubmed: 12525534
Am J Med Genet A. 2004 Aug 30;129A(2):149-55
pubmed: 15316969
Orphanet J Rare Dis. 2016 Oct 7;11(1):137
pubmed: 27717373
J Am Soc Nephrol. 2004 Apr;15(4):998-1007
pubmed: 15034102
J Biol Chem. 2001 Aug 17;276(33):31124-32
pubmed: 11349135
Hum Mutat. 2013 Dec;34(12):1611-4
pubmed: 24027040
Nat Genet. 2003 Jun;34(2):203-8
pubmed: 12766769
BMC Med Genet. 2016 Nov 17;17(1):84
pubmed: 27855655

Auteurs

Rajesh Madhu (R)

Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; Paediatric Neurosciences Department, Alder Hey Children's Hospital NHS Foundation Trust, Liverpool, UK.

Glenda M Beaman (GM)

Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, UK.

Kate E Chandler (KE)

Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, UK.

James O'Sullivan (J)

Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, UK.

Jill E Urquhart (JE)

Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, UK.

Naz Khan (N)

Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, UK.

Elizabeth Martindale (E)

Department of Obstetrics and Gynaecology, Royal Blackburn Hospital, Blackburn, UK.

Tracy A Briggs (TA)

Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, UK.

Jill Clayton-Smith (J)

Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, UK.

Jenny Higgs (J)

Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, UK; Liverpool Centre for Genomic Medicine, Liverpool Women's Hospital, Liverpool, UK.

Gauri Batra (G)

Royal Manchester Children's Hospital, Manchester University NHS Foundation Trust, Manchester, UK.

Bronwyn Kerr (B)

Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, UK.

Adrian S Woolf (AS)

Royal Manchester Children's Hospital, Manchester University NHS Foundation Trust, Manchester, UK; Division of Cell Matrix Biology & Regenerative Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.

William G Newman (WG)

Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, UK. Electronic address: william.newman@manchester.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH